tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Graham Doyle

Graham Doyle

UBS
Wall Street Analyst
Ranked #7,143 out of 8,047 Analysts on TipRanks (#19,092 out of 21,521 overall experts)

Success Rate

29%
5 out of 17 Profitable Transactions

Average Return

-12.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Graham Doyle's ratings since 2019 and opened each position for the duration of 1 Year:
29.41% of your transactions would have been profitable with an average return of -12.2%

Stock Rating Distribution

34Ratings
50.00% Buy
35.29% Hold
14.71% Sell
Distribution of Graham Doyle's ratings

Additional Information

Main Sector:General
Geo Coverage:
United KingdomUK Market
United StatesUS Market

Best Rating

Stock:
Carl Zeiss Meditec
(0DHC)
Rating Type:Buy
Dates:May 13, 2022 - Jan 01, 1970
Gain:21.70%
The most profitable rating made by Graham Doyle

Graham Doyle's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Roche Holding AG
Jun 20, 2019
Hold
Downgraded
$292.06
(-9.74% Downside)
0.00%
1
Bayer
Jan 22, 2020
Buy
Reiterated
€90.00
(66.91% Upside)
0%
-26.60%
1
GlaxoSmithKline
May 28, 2020
Hold
Reiterated
0.00%
3
AstraZeneca
May 29, 2020
Buy
Reiterated
25%
-3.35%
5
Novo Nordisk
Jan 25, 2022
Sell
Downgraded
0%
-24.90%
2
Fresenius SE & Co. KGaA
Mar 15, 2022
Hold
Reiterated
€30.00
(21.85% Upside)
0.00%
2
Smith & Nephew
Apr 29, 2022
Hold
Reiterated
1,295.00p
(22.37% Upside)
0.00%
2
Koninklijke Philips N.V.
Jul 25, 2022
Sell
Reiterated
€16.00
(-17.68% Downside)
100%
+6.65%
6
Fresenius Medical Care AG & Co. KGaA
Jul 27, 2022
Buy
Reiterated
€68.00
(84.05% Upside)
0%
-30.20%
7
Siemens Healthineers AG
Aug 03, 2022
Hold
Reiterated
$60.55
(22.48% Upside)
0.00%
1
List of latest recommendations made by Graham Doyle. Click to expand and see Graham Doyle's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More